Peptides Derived of Kunitz-Type Serine Protease Inhibitor as Potential Vaccine Against Experimental Schistosomiasis
Schistosomiasis is a significant public health problem in sub-Saharan Africa, China, Southeast Asia, and regions of South and Central America affecting about 189 million people. Kunitz-type serine protease inhibitors have been identified as important players in the interaction of other flatworm para...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2019
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/24088
- Acceso en línea:
- https://doi.org/10.3389/fimmu.2019.02498
https://repository.urosario.edu.co/handle/10336/24088
- Palabra clave:
- CD1 antigen
Epitope
Ion channel
Serine proteinase inhibitor
Vaccine
Adult
Animal experiment
Animal model
Animal tissue
Article
Bioinformatics
Biomphalaria glabrata
Cercaria
Controlled study
Drug efficacy
Echinococcus multilocularis
Enzyme linked immunosorbent assay
Fasciola hepatica
Female
Fibrinolysis
Gene expression
Inflammation
Molecular genetics
Mouse
Nonhuman
Peptide synthesis
Polymerase chain reaction
Reversed phase high performance liquid chromatography
Schistosoma granulosus
Schistosoma haematobium
Schistosoma japonicum
Schistosoma mansoni
Schistosomiasis
Schistosomulum
Stereomicroscopy
Upregulation
Vaccination
ADAD vaccination system
Helminth vaccines
Immunomodulator AA0029
Kunitz-type proteins
Schistosoma mansoni
Synthetic peptide
- Rights
- License
- Abierto (Texto Completo)